Differential levels of tissue hypoxia in the developing chicken heart

Developmental Dynamics

Volumn 235, Issue 1, 2006, Pages 115-123

  Wikenheiser, Jamie ^a   Doughman, Yong Qiu ^a   Fisher, Steven A ^b   Watanabe, Michiko ^a,c  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Apoptosis; Cardiac development; Cardiomyocytes; Central conduction system; His Purkinje system; Hypoxia; Interventricular septum

Indexed keywords

2 (2 NITRO 1H IMIDAZOL 1 YL) N (2,2,3,3,3 PENTAFLUOROPROPYL)ACETAMIDE; ANTIGEN; HETERODIMER; HNK 1 ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OXYGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CHICKEN; CORONARY ARTERY; HEART ATRIUM; HEART MUSCLE; HEART VENTRICLE SEPTUM; HYPOXEMIA; IMMUNOHISTOCHEMISTRY; NONHUMAN; OXYGEN CONCENTRATION; PRIORITY JOURNAL; SINUS NODE; ANIMAL; ANOXIA; CELL NUCLEUS; CHICK EMBRYO; COMPARATIVE STUDY; CORONARY BLOOD VESSEL; HEART; METABOLISM; PRENATAL DEVELOPMENT;

ANIMALS; ANOXIA; CELL NUCLEUS; CHICK EMBRYO; CORONARY VESSELS; HEART; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MYOCARDIUM;

EID: 33644968171     PISSN: 10588388     EISSN: 10970177     Source Type: Journal    
DOI: 10.1002/dvdy.20499     Document Type: Article

References (64)

1. Banasiak K, Xia Y, Haddada G. 2000. Mechanisms underlying hypoxia-induced neuronal apoptosis. Prog Neurobiol 62:215-249.
2. Bergeron M, Evans S, Sharp F, Koch C, Lord E, Ferriero D. 1999. Detection of hypoxic cells with the 2-nitroimidazole, EF5, correlates with early redox changes in rat brain after perinatal hypoxia-ischemia. Neuroscience 89:1357-1366.
3. Bernanke D, Velkey J. 2002. Development of the coronary blood supply: changing concepts and current ideas. Anat Rec 269: 198-208.
4. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A. 1996. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380:435-439.
5. Chan-Thomas P, Thompson R, Robert B, Yacoub M, Barton P. 1993. Expression of homeobox genes Msx-1 (Hox-7) and Msx-2 (Hox-8) during cardiac development in the chick. Dev Dyn 197:203-216.
6. Chen E, Fujinaga M, Giaccia A. 1999. Hypoxia microenvironment within an embryo induces apoptosis and is essential for proper morphological development. Teratology 60:215-225.
7. Cheng G, Wessels A, Gourdie R, Thompson R. 2002. Spatiotemporal and tissue specific distribution of apoptosis in the developing chick heart. Dev Dyn 223:119-133.
8. Chuck E, Watanabe M. 1997. Differential expression of PSA-NCAM and HNK-1 epitopes in the developing cardiac conduction system of the chick. Dev Dyn 209:182-195.
9. Chuck E, Freeman D, Watanabe M, Rosenbaum D. 1997. Changing activation sequence in the embryonic chick heart: implications for the development of the His-Purkinje system. Circ Res 81:470-476.
10. Clyman R, Chan C, Mauray F, Chen Y, Cox W, Seidner S, Lord E, Weiss H, Waleh N, Evans S, Koch C. 1999. Permanent anatomic closure of the ductus arteriosus in newborn baboons: the roles of postnatal constriction, hypoxia, and gestation. Pediatr Res 45:19-29.
11. Dery M-AC, Michaud M, Richard D. 2005. Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators. Int J Biocem Cell Biol 37:535-540.
12. Eralp I, Lie-Venema H, DeRuiter M, van der Akker N, Bogers A, Mentink M, Poelmann R, Gittenberger-de Groot A. 2005. Coronary artery and orifice development is associated with proper timing of epicardial outgrowth and correlated Fas ligand associated apoptosis patterns. Cir Res 96:1-9.
13. Evans S, Hahn S, Pook D, Jenkins W, Chalian A, Zhang P, Stevens C, Weber R, Weinstein G, Benjamin I, Mirza N, Morgan M, Rubin S, McKenna W, Lord E, Koch C. 2000a. Detection of hypoxia in human squamous cell carcinoma by EF5 binding. Cancer Res 60:2018-2024.
14. Evans S, Kachur A, Shiue C, Hustinx R, Jenkins W, Shive G, Karp J, Alavi A, Lord E, Dolbier W, Koch C. 2000b. Non-invasive detection of tumor hypoxia using the 2-nitroimidazole [18F] EF1. J Nucl Med 41:327-336.
15. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea K, Powell-Braxton L, Hillan K, Moore M. 1996. Heterozygous embryonic lethality induced by target inactivation of the VEGF gene. Nature 380: 439-442.
16. Forsythe J, Jiang B, Iyer N, Agani F, Leung S, Koos R, Semenza G. 1996. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16:4604-4613.
17. Frommelt P, Frommelt M. 2004. Congenital coronary artery anomalies. Pediatr Clin North Am 51:1273-1288.
18. Graham R, Frazier D, Thompson J, Haliko S, Li H, Wasslauf B, Spiga M, Bishopric N, Webster K. 2004. A unique pathway of cardiac myocyte death caused by hypoxia-acidosis. J Exp Biol 207:3189 3200.
19. Greijer A, van der Wall E. 2004. The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J Clin Pathol 57:1009-1014.
20. Huang L, Arany Z, Livingston D, Bunn H. 1996. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its a subunit. J Biol Chem 271:32253-32259.
21. Huang Y, Hicky RP, Yeh JL, Liu D, Dadak A, Young LH, Johnson RS, Giordano FJ. 2004. Cardiac myocyte specific HIF1a deletion alters vascularization, energy availability, calcium flux, and contractility in the normoxic heart. FASEB J 18: 1138-1140.
22. Ikeda T, Iwasaki K, Shimokawa I, Sakai H, Ito H, Matsuo T. 1990. Leu-7 immunoreactivity in human and rat embryonic hearts, with special reference to the development of the conduction tissue. Anat Embryol (Berl) 182:553-562.
23. Iyer N, Kotch L, Agani F, Leung S, Laughner E, Wenger R, Gassmann M, Gearhart J, Lawler A, Yu A, Semenza G. 1998. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1a. Genes Dev 12:149-162.
24. Jiang B, Semenza G, Bauer C, Marti H. 1996. Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. Am J Physiol 271:C1172-C1180.
25. Jiang B, Zheng J, Leung S, Roe R, Semenza G. 1997. Transactivation and inhibitory domains of hypoxia-inducible factor la: modulation of transcriptional activity by oxygen tension. J Biol Chem 272:19253-19260.
26. Jureidini S, Marino C, Rao P. 1998. Congenital coronary artery abnormalities. Indian J Pediatr 65:217-229.
27. Kajino H, Chen Y, Chemtob S, Waleh N, Koch C, Clyman R. 2000. Tissue hypoxia inhibits prostaglandin and nitric oxide production and prevents ductus arteriosus reopening. Am J Physiol Regul Integr Comp Physiol 279:R278-R286.
28. Kattan J, Dettman R, Bristow J. 2004. Formation and remodeling of the coronary vascular bed in the embryonic avian heart. Dev Dyn 230:34-43.
29. Koch C. 2002. Measurements of absolute oxygen levels in cells and tissues using oxygen sensors and the 2-nitroimidazole EF5. Methods Enzymol 352:3-31.
30. Lamers W, Wessels A, Verbeek F, Moorman A, Viragh S, Wenick A, Gittenberger-de Groot A, Anderson R. 1992. New findings concerning ventricular septation in the human heart. Implications formaldevelopment. Circulation86:1194-1205.
31. Lee J, Siemann D, Koch C, Lord E. 1996. Direct relationship between radiobiological hypoxia in tumors and monoclonal antibody detection of EF5 cellular adducts. Int J Cancer 67:372-378.
32. Lord E, Harwell L, Koch C. 1993. Detection of hypoxic cells by monoclonal antibody recognizing 2-nitroimidazole adducts. Cancer Res 53:5721-5726.
33. Miquerol L, Gertsenstein M. Harpal K, Rossant J, Nagy A. 1999. Multiple developmental roles of VEGF suggested by a lacz-tagged allele. Dev Biol 212:307-322.
34. Miquerol L, Langille B, Nagy A. 2000. Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression. Development 127:3941-3946.
35. Miyamoto T, Zhang L, Sekiguchi A, Hadama T, Shimada T. 2002. Structural differences in the cytoarchitecture and intercalated discs between the working myocardium and conduction system in the human heart. Heart Vessels 16:232-240.
36. Okunieff P, Hoeckel M, Dumphy E, Schlenger K, Knoop C, Vaupel P. 1993. Oxygen tension distribution are sufficient to explain the local response of human breast tumors treated with radiation alone. Int J Radiat Oncol Biol Phys 26: 631-636.
37. Overgaard J. 1992. Importance of tumor hypoxia in radiotherapy. A meta-analysis of controlled clinical trials. Radiother Oncol 24:S64.
38. Piret J, Mottet D, Raes M, Michiels C. 2002. Is HIF-1 alpha a pro- or anti-apoptotic protein? Biochem Pharmacol 64: 889-892.
39. Poelmann R, Gittenberger-de Groot A. 1999. A subpopulation of apoptosis-prone cardiac neural crest cells target to the venous pole: multiple functions in heart development? Dev Biol 207:271-286.
40. Pugh C, O'Rourke J, Nagao M, Gleadle J, Ratcliffe P. 1997. Activation of hypoxia-inducible factor-1; Definition of regulatory domains within the a subunit. J Biol Chem 272:11205-11214.
41. Rothenberg F, Hitomi M, Fisher S, Watanabe M. 2002. Initiation of apoptosis in the developing avian outflow tract myocardium. Dev Dyn 223:469-482.
42. Ryan H, Lo J, Johnson R. 1998. HIF-1a is required for solid tumor formation and embryonic vascularization. EMBO J 17: 3005-3015.
43. Saikumar P, Venkatachalam M. 2003. Role of apoptosis in hypoxic/ischemic damage in the kidney. Semin Nephrol 23:511-521.
44. Semenza G. 1998. Hypoxia-inducible factor 1: master regulator of O2 homeostasis. Curr Opin Genet Dev 8:588-594.
45. Semenza G. 2000. Expression of hypoxia-inducible factor 1: mechanisms and consequences. Biochem Pharmacol 59:47-53.
46. Semenza G. 2003. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3:721-732.
47. Semenza G, Wang G. 1992. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 12:5447-5454.
48. Semenza G, Jiang B, Leung S, Passantino R, Concordet J, Maire P, Giallongo A. 1996. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem 271:32529-32537.
49. Sharma P, Anderson R, Copp A, Henderson D. 2004. Spatiotemporal analysis of programmed cell death during mouse cardiac separation. Anat Rec 277A:355-369.
50. Shimizu T, Dennis J, Masaki T, Fischman D. 1985. Axial arrangement of the myosin rod in vertebrate thick filaments: immunoelectron microscopy with a monoclonal antibody to light meromyosin. J Cell Biol 101:1115-1123.
51. Sugishita Y, Watanabe M, Fisher S. 2004a. Role of myocardial hypoxia in the remodeling of the embryonic avian cardiac outflow tract. Dev Biol 267:294-308.
52. Sugishita Y, Leifer D, Watanabe M, Agani F, Fisher S. 2004b. Hypoxia-responsive signaling regulates the apoptosis-dependent remodeling of the embryonic avian cardiac outflow tract. Dev Biol 273:285-296.
53. Sugishita Y, Watanabe M, Fisher S. 2004c. The development of the embryonic outflow tract provides novel insights into cardiac differentiation and remodeling. Trends Cardiovasc Med 14:235-241.
54. Tomanek R, Ratajska A, Kitten G, Yue X, Sandra A. 1999. Vascular endothelial growth factor expression coincides with coronary vasculogenesis and angiogenesis. Dev Dyn 215:54-61.
55. Urtasun R, Coleman C, Wasserman T, Phillips T. 1984. Clinical trials with hypoxic cell sensitizers: time to retrench or time to push forward? Int J Radiat Oncol Biol Phys 10:1691-1696.
56. Varghese A, Gulyas S, Mohindra J. 1976. Hypoxia-dependent reduction of 1-(2-nitro-1-imidazolyl)-3-methoxy-2-propanol by Chinese hamster ovary cells and KHT tumor cells in vitro and in vivo. Cancer Res 36:3761-3765.
57. Viragh S, Challice C. 1981. The origin of the epicardium and the embryonic myocardial circulation of the mouse. Anat Rec 201:157-168.
58. Vrancken Peeters M, Gittenberger-de Groot A, Mentink M, Hungerford J, Little C, Poelmann R. 1997. The development of the coronary vessels and their differentiation into arteries and veins in the embryonic quail heart. Dev Dyn 208: 338-348.
59. Wang G, Jiang B, Rue E, Semenza G. 1995. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A 92:5510-5514.
60. Watanabe M, Timm H, Fallah-Najmabadi H. 1992. Cardiac expression of polysialylated NCAM in the chicken embryo: correlation with the ventricular conduction system. Dev Dyn 194: 128-141.
61. Wessels A, Vermeulen J, Verbeek F, Viragh S, Kalman F, Lamers W, Moorman A. 1992. Spatial distribution of "tissue specific" antigens in the developing human heart and skeletal muscle. Anat Rec 232:97-111.
62. Woods M, Koch C, Lord E. 1996. Detection of individual hypoxic cells in multicellular spheroids by flow cytometry using the 2-nitroimidazole, EF5, and monoclonal antibodies. Int J Radiat Oncol Biol Phys 34:93-101.
63. Young S, Marshall R, Hill R. 1988. Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proc Natl Acad Sci U S A 85:9533-9537.
64. Yu A, Frid M, Shimoda L, Wiener C, Stenmark K, Semenza G. 1998. Temporal, spatial and oxygen-regulated expression of hypoxia-inducible factor 1 in the lung. Am J Physiol 275:L818-L826.